OR WAIT null SECS
September 04, 2012
Bristol-Myers Squibb has initiated a voluntary recall of 10 lots of BiCNU (carmustine for injection) previously manufactured by Ben Venue Laboratories, a former, third-party contract manufacturer for the company, to the user level.
September 02, 2012
A review of taints and odors in the pharmaceutical and consumer healthcare industries.
Industry and academia advance novel approaches for achieving enanioselectivity.
The authors investigate the tablet-coating process using a combination of different simulation techniques.
September 01, 2012
Pfizer has two manufacturing facilities in Germany for high-potency manufacturing, respectively in Freiburg and Illertissen. Pharmaceutical Technology's Executive Editor Patricia Van Arnum visited the facilities and spoke to the company about the design and operation of these facilities.
The authors describe a QbD study that was performed to optimize a coating system.
The authors explain chemical transformations that are achievable through certain biocatalytic routes.
Policymakers must balance fundamental issues involving access to medicines and pricing.
An industry roundtable representing Metrics, Cambrex, Carbogen Amcis, Euticals, Ferro Pfanstiehl, and SAFC.
The author discusses the key provisions of GDUFA as they relate to the pharmaceutical supply chain, including parity of inspections between domestic and foreign sites for both finished dosage forms and APIs of generic drugs.